Pfiz­er bris­tles at 'mis­lead­ing' com­ments from Big Phar­ma ri­vals Am­gen, Genen­tech on biosim­i­lars

Tak­ing is­sue with Am­gen, Genen­tech and oth­er ref­er­ence prod­uct spon­sors’ dis­sem­i­na­tion of mis­lead­ing in­for­ma­tion on biosim­i­lars, Pfiz­er is ask­ing the FDA to take ac­tion with …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER